Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,258 public trials 1,193 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Completed

A Study of the Safety, Tolerability and Pharmacokinetics of ABBV-368 as a Single Agent and Combination in Subjects With Locally Advanced or Metastatic Solid Tumors

NCT03071757

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +58 more
Locations
  • Moores Cancer Center at UC San Diego /ID# 201334 La Jolla, California, United States
  • University of California, Davis Comprehensive Cancer Center /ID# 201342 Sacramento, California, United States
  • Stanford University /ID# 206949 Stanford, California, United States
  • Yale University /ID# 207895 New Haven, Connecticut, United States
View all 27 locations
View Trial Details
Completed

Evaluate the Impact of Afatinib on Quality of Life and Symptom Burden of Greek Subjects With Advanced NSCLC in Routine Patient Care Settings

NCT02440854

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • University General Hospital of Evros Alexandroupoli, Greece
  • Chest Hospital of Athens "Sotiria" Athens, Greece
  • "Attikon" University General Hospital of Attica Haidari, Greece
  • University General Hospital of Heraklion Heraklion, Greece
View Trial Details
Completed

Study Of OX40 Agonist PF-04518600 Alone And In Combination With 4-1BB Agonist PF-05082566

NCT02315066

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +60 more
Locations
  • The Angeles Clinic And Research Institute, A Cedars-Sinai Affiliate Los Angeles, California, United States
  • Keck Hospital of USC Los Angeles, California, United States
  • LAC+USC Medical Center Los Angeles, California, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 30 locations
View Trial Details
Completed

Safety, Tolerability, Immunogenicity, and Antitumor Activity of GEN-009 Adjuvanted Vaccine

NCT03633110

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +39 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • John Wayne Cancer Institute - Providence Saint John's Health Center Santa Monica, California, United States
  • University of Colorado, Anschutz Cancer Pavilion Aurora, Colorado, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

Combination Therapy of F16IL2 and Paclitaxel in Solid Tumour Patients

NCT01134250

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +23 more
Locations
  • A.O. UNIVERSITARIA OSPEDALI RIUNITI - OSPEDALE UMBERTO I DI ANCONA - ANCONA (AN) (Italy) Ancona, Italy
  • Irst - Istituto Scientifico Romagnolo Per Lo Studio E La Cura Dei Tumori - Meldola (Fc) Meldola, Italy
  • European Institute of Oncology Milan, Italy
  • A.O. UNIVERSITARIA POLICLINICO DI MODENA (Italy) Modena, Italy
View Trial Details
Completed

A Study of Budigalimab (ABBV-181) in Participants With Advanced Solid Tumors

NCT03000257

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +56 more
Locations
  • Moores Cancer Center at UC San Diego /ID# 157374 La Jolla, California, United States
  • The University of Chicago Medical Center /ID# 157375 Chicago, Illinois, United States
  • Carolina BioOncology Institute /ID# 157376 Huntersville, North Carolina, United States
  • South Texas Accelerated Research Therapeutics /ID# 157378 San Antonio, Texas, United States
View all 26 locations
View Trial Details

Related conditions